The FDA has just approved a drug for RLS - which apparently stands for Restless Leg Syndrome. First you have to love the name of this drug - Requip. Second, the fact that there is something called restless leg syndrome. This from the news release on WebMd;
May 6, 2005 -- The FDA has approved Requip to treat moderate-to-severe restless legs syndrome (RLS). Requip was first approved by the FDA in 1997 to treat Parkinson's disease.
RLS affects nearly 10% of the population, says the FDA. The condition is characterized by an urge to move the legs, usually accompanied by or caused by uncomfortable leg sensations like a creepy-crawly feeling, tingling, pulling, or pain.
For most people with RLS, symptoms begin or worsen during periods of rest or inactivity and are partially or totally relieved by movement. (partially or totally relieved by movement how is this a condition? ) Symptoms typically worsen or occur only in the evening or at night, and can disturb sleep (well that isn't great but aren't there a lot of reasons people over 50 can't sleep?)
Woman are twice as likely to be affected by the condition compared with men, and the condition can worsen with age. At first, restless legs syndrome symptoms may be mild and sporadic, but over time they may get worse. After age 50, many people with restless legs syndrome have daily symptoms (why not then take a walk, or dance a few steps.) and significant sleep problems (would they have these problems if they were more mobile?).
The cause of restless legs syndrome is not known. In some people, it's a primary condition, which means it's not caused by another health factor. In others, it may be a secondary condition linked to pregnancy (pregnancy is a secondary condition?), iron deficiency, or renal (kidney) failure....
Common side effects of Requip reported in the studies include nausea, headache, and vomiting, says the FDA. ( I for one would certainly opt for the drug and the possibility of vomiting rather than walking.)
The drug's label will also include a caution that Requip has been associated with sedating effects, including somnolence (sleepiness) and the possibility of falling asleep while engaged in activities of daily living, including driving.
Fainting (syncope) or low blood pressure (symptomatic hypotension) may occur, particularly during initial treatment or dosing, says the FDA.
I just find this amazing and needed to post it. Last night I saw an ad for another drug to combat ADDS - Adult Attention Deficit Disorder. It was remarkable. Shot as if throught the computerized eyes of the Terminator it showed a man gaining or losing points as he went through life. Late on a report, late to meet friends his score went down, after taking the drug which remarkably is called Strattera (the ethical issues the ad brings up is the subject of this article).
Recent Comments
catbobcat (crossing a road in Redding, CT.) blogging